Entering text into the input field will update the search result below

Johnson & Johnson terminating COVID-19 vaccine contract with Emergent - WSJ

Johnson & Johnson Inc. Canada"s facility in Markham, On, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • Johnson & Johnson (NYSE:JNJ) has notified Emergent BioSolutions (NYSE:EBS) it is terminating its supply deal with the contract manufacturer, with the pharma giant accusing Emergent of breaching a contract, The

Recommended For You

Related Stocks

SymbolLast Price% Chg
JNJ
--
EBS
--